Clinical Trial Update: Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of pembrolizumab with olaparib for metastatic pancreatic cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Olaparib (Olaparib)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Cambridge University Hospitals NHS Foundation Trust | Conditions: Pancreatic Cancer | Phase 2 | Status: RECRUITING